Quest PharmaTech Inc. QPTFF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 321.20K | 342.00K | 337.60K | 363.40K | 337.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 492.90K | 519.00K | 511.80K | 564.70K | 571.00K |
| Operating Income | -492.90K | -519.00K | -511.80K | -564.70K | -571.00K |
| Income Before Tax | 3.51M | 3.24M | 3.59M | -54.10K | -805.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.51 | 3.24 | 3.59 | -0.05 | -0.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.51M | 3.24M | 3.59M | -54.10K | -805.90K |
| EBIT | -492.90K | -519.00K | -511.80K | -564.70K | -571.00K |
| EBITDA | -- | -- | -- | -194.50K | -373.60K |
| EPS Basic | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 676.52M | 676.52M | 676.52M | 676.52M | 676.52M |
| Average Diluted Shares Outstanding | 676.52M | 676.52M | 676.52M | 676.52M | 676.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |